Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The ubiquitin-proteasome system in Alzheimer's disease.

Oddo S.

J Cell Mol Med. 2008 Apr;12(2):363-73. doi: 10.1111/j.1582-4934.2008.00276.x. Epub 2008 Feb 8. Review.

2.

Protein quality control in Alzheimer's disease by the ubiquitin proteasome system.

de Vrij FM, Fischer DF, van Leeuwen FW, Hol EM.

Prog Neurobiol. 2004 Dec;74(5):249-70. Review.

PMID:
15582222
3.

Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.

Hong L, Huang HC, Jiang ZF.

Neurol Res. 2014 Mar;36(3):276-82. doi: 10.1179/1743132813Y.0000000288. Review.

PMID:
24512022
4.

Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system.

Lee MJ, Lee JH, Rubinsztein DC.

Prog Neurobiol. 2013 Jun;105:49-59. doi: 10.1016/j.pneurobio.2013.03.001. Epub 2013 Mar 23. Review.

PMID:
23528736
5.

The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system.

Tai HC, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT.

Am J Pathol. 2012 Oct;181(4):1426-35. doi: 10.1016/j.ajpath.2012.06.033. Epub 2012 Aug 4. Erratum in: Am J Pathol. 2012 Nov;181(5):1889-90.

6.

The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Sulistio YA, Heese K.

Mol Neurobiol. 2016 Mar;53(2):905-31. doi: 10.1007/s12035-014-9063-4. Epub 2015 Jan 7. Review.

PMID:
25561438
7.

Alzheimer's disease meets the ubiquitin-proteasome system.

Song S, Jung YK.

Trends Mol Med. 2004 Nov;10(11):565-70. Review.

PMID:
15519283
8.

Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.

Rosen KM, Moussa CE, Lee HK, Kumar P, Kitada T, Qin G, Fu Q, Querfurth HW.

J Neurosci Res. 2010 Jan;88(1):167-78. doi: 10.1002/jnr.22178.

9.

Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system.

van Leeuwen FW, Hol EM, Fischer DF.

J Alzheimers Dis. 2006;9(3 Suppl):319-25. Review.

PMID:
16914870
10.

The role of the ubiquitin proteasome system in Alzheimer's disease.

Riederer BM, Leuba G, Vernay A, Riederer IM.

Exp Biol Med (Maywood). 2011 Mar;236(3):268-76. doi: 10.1258/ebm.2010.010327. Epub 2011 Mar 7. Review.

PMID:
21383047
11.

The Proteasome and Oxidative Stress in Alzheimer's Disease.

Bonet-Costa V, Pomatto LC, Davies KJ.

Antioxid Redox Signal. 2016 Dec 1;25(16):886-901. Epub 2016 Aug 25. Review.

PMID:
27392670
12.

The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease.

Gadhave K, Bolshette N, Ahire A, Pardeshi R, Thakur K, Trandafir C, Istrate A, Ahmed S, Lahkar M, Muresanu DF, Balea M.

J Cell Mol Med. 2016 Jul;20(7):1392-407. doi: 10.1111/jcmm.12817. Epub 2016 Mar 29. Review.

14.

Effects of corticosterone and amyloid-beta on proteins essential for synaptic function: implications for depression and Alzheimer's disease.

Wuwongse S, Cheng SS, Wong GT, Hung CH, Zhang NQ, Ho YS, Law AC, Chang RC.

Biochim Biophys Acta. 2013 Dec;1832(12):2245-56. doi: 10.1016/j.bbadis.2013.07.022. Epub 2013 Aug 6.

15.

Role of the ubiquitin proteasome system in Alzheimer's disease.

Upadhya SC, Hegde AN.

BMC Biochem. 2007 Nov 22;8 Suppl 1:S12. Review.

16.

Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.

Caccamo A, Branca C, Talboom JS, Shaw DM, Turner D, Ma L, Messina A, Huang Z, Wu J, Oddo S.

J Neurosci. 2015 Oct 14;35(41):14042-56. doi: 10.1523/JNEUROSCI.2781-15.2015.

17.

Understanding the cause of sporadic Alzheimer's disease.

Zetterberg H, Mattsson N.

Expert Rev Neurother. 2014 Jun;14(6):621-30. doi: 10.1586/14737175.2014.915740. Review.

PMID:
24852227
18.

Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.

Hossini AM, Megges M, Prigione A, Lichtner B, Toliat MR, Wruck W, Schröter F, Nuernberg P, Kroll H, Makrantonaki E, Zouboulis CC, Adjaye J.

BMC Genomics. 2015 Feb 14;16:84. doi: 10.1186/s12864-015-1262-5. Erratum in: BMC Genomics. 2015;16:433. Zoubouliss, Christos C [corrected to Zouboulis, Christos C].

19.

Abeta inhibits the proteasome and enhances amyloid and tau accumulation.

Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM.

Neurobiol Aging. 2008 Nov;29(11):1607-18. Epub 2007 Jun 1.

20.

The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease.

Ihara Y, Morishima-Kawashima M, Nixon R.

Cold Spring Harb Perspect Med. 2012 Aug 1;2(8). pii: a006361. doi: 10.1101/cshperspect.a006361.

Supplemental Content

Support Center